Single-fraction or multi-fraction stereotactic ablative body radiotherapy followed by atezolizumab in advanced triple-negative breast cancer: a randomized phase II trial
S
Steven David
P
Peter Savas
S
Shankar Siva
M
Mathias Bressel
M
Michelle White
B
Bronte Nikolic
M
Michael W. Neeson
S
Shane White
G
Gavin Marx
R
Robyn Cheuk
M
Michelle Grogan
M
Maria Farrell
J
Jessica Foudoulis
P
Paul J. Neeson
S
Sherene Loi
Article Details
Journal
Nature Communications
Volume / Issue
Vol. 1, Issue 1
Published
July 27, 2026
ISSN
2041-1723
Publisher
Nature Portfolio
Authors (15)
S
Steven David
P
Peter Savas
S
Shankar Siva
M
Mathias Bressel
M
Michelle White
B
Bronte Nikolic
M
Michael W. Neeson
S
Shane White
G
Gavin Marx
R
Robyn Cheuk
M
Michelle Grogan
M
Maria Farrell
J
Jessica Foudoulis
P
Paul J. Neeson
S
Sherene Loi
Related Articles from this Journal
Synthesis of adaptive 15N-nitrosyl-Co7 nanocluster for electrocatalytic C–H functionalization
Chao Wu, Xu Zhang et al.
Aug 2026
10.1038/s41467-026-76516-1
Pan-Ebolavirus nanoparticle vaccine provides protection in rodents from lethal infection by Zaire and Sudan viruses
Connor Weidle, Natalie Brunette et al.
Aug 2026
10.1038/s41467-026-76114-1
Multi-population GWAS meta-analysis identifies bladder cancer susceptibility loci and highlights genetic regulation of smoking-related risk
Ludmila Prokunina-Olsson, Oscar Florez-Vargas et al.
Aug 2026
10.1038/s41467-026-76157-4
Genome-wide annotation of human multi-nucleotide variants reveals widespread functional differences from single nucleotide variants
Weiwei Jin, Wen Cao et al.
Aug 2026
10.1038/s41467-026-76470-y
Allele-specific chromatin architecture shapes imprinted domains and coordinates a distal enhancer and antisense transcription at the mouse Mest-Copg2 domain
Bongmin Bae, Katherine Gu et al.
Aug 2026
10.1038/s41467-026-76506-3